Blog

New Immunotherapy Combination Tolerable, Effective in Patients with Advanced Kidney Cancer – Drug Discovery & Development


New Immunotherapy Combination Tolerable, Effective in Patients with Advanced Kidney Cancer
Drug Discovery & Development
Combining an anti-angiogenesis agent, which blocks blood vessel formation, with an immunotherapy agent was found to have promising anti-tumor activity and no unexpected side effects in an early-phase clinical trial in patients with advanced kidney ...

Flattr this!

2018-02-13 NEWS
About Michael Zand